Ken Heebner’s Capital Growth Management’s Portfolio: 5 Dividend Stock Picks

Page 1 of 5

In this article, we discuss the dividend stocks in Ken Heebner’s portfolio. If you want to read our detailed analysis of Capital Growth Management’s past performance and Heebner’s investment strategy, go directly to read Ken Heebner’s Capital Growth Management’s Portfolio: 10 Dividend Stock Picks

5. MetLife, Inc. (NYSE:MET)

Number of Hedge Fund Holders: 39
Capital Growth Management’s Stake Value: $34,789,000
Dividend Yield as of May 24: 3.15%

MetLife, Inc. (NYSE:MET) is an American insurance company with around 90 million customers in over 60 countries. The company announced its Q1 2022 results on May 5 and reported revenue of $17.7 billion, which presented a 6% year-over-year growth. Moreover, the company’s EPS of $2.08 beat the market consensus by $0.45.

In April, MetLife, Inc. (NYSE:MET) announced a 4.2% growth in its quarterly dividend to $0.50 per share, with a dividend yield of 3.15%, as of the close of May 24. Since 2011, the company has raised its quarterly dividend at a CAGR of 9.5%.

Capital Growth Management initiated its position in MetLife, Inc. (NYSE:MET) during the first quarter of 2022, purchasing shares worth over $34.7 million. The company accounted for 3.2% of Ken Heebner’s portfolio. In May, Citigroup initiated its coverage of MetLife, Inc. (NYSE:MET) with a Buy rating and a $77 price target.

Pzena Investment Management was the largest shareholder of MetLife, Inc. (NYSE:MET) in Q1 2022, holding shares worth roughly $360 million. Overall, 39 hedge funds tracked by Insider Monkey were bullish on the company in Q1 2022, up from 36 in the previous quarter. These stakes hold a consolidated value of over $945.5 million.

Page 1 of 5